Yuan Xu - Jan 4, 2022 Form 3 Insider Report for Xilio Therapeutics, Inc. (XLO)

Role
Director
Signature
/s/ Chris Frankenfield, Attorney-in-Fact
Stock symbol
XLO
Transactions as of
Jan 4, 2022
Transactions value $
$0
Form type
3
Date filed
1/6/2022, 05:40 PM
Previous filing
Aug 5, 2021
Next filing
Jun 3, 2022

No securities are beneficially owned.